YAACOV MICHLIN

BioLight Life Sciences Ltd

Yaacov Michlin serves as CEO of BioLight [TASE: BOLT] and presides as the Chairman or Director in most of BioLight’s portfolio companies. BioLight manages and invests in companies in Ophthalmology and currently has 9 portfolio companies. Prior to joining BioLight, Yaacov served as CEO and President of Brainsway. Yaacov led Brainsway to significant sales growth in the US and later to an IPO on the NASDAQ. Currently, Yaacov serves as the Co-Chairman (Life Sciences) of IATI – the umbrella organization of high-tech and biomed companies in Israel. Prior to Brainsway, Yaacov served as president and CEO of Yissum – The technology Transfer Company of the Hebrew University of Jerusalem. Yaacov has also founded and served as Chairman of Integra Holdings, an investment company that invests in life sciences ventures based on research at the Hebrew University of Jerusalem. Mr. Michlin holds a Bachelor of Law and Economics, cum laude, and a Master of Law degree, both from Bar-Ilan University, Israel, and an MBA, cum laude, from the Technion Israel Institute of Technology, majoring in high-tech management.